Inhibition of platelet thromboxane A2 synthase activity by sodium 5-(3′-pyridinylmethyl)benzofuran-2-carboxylate
- 1 August 1983
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 26 (2) , 325-342
- https://doi.org/10.1016/0090-6980(83)90099-0
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASEThe Lancet, 1981
- Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin.Journal of Clinical Investigation, 1981
- Comparison in anesthetized dogs of the anti-aggregatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6a-carba-PGI2 (carbacyclin)Prostaglandins, 1980
- Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.Proceedings of the National Academy of Sciences, 1979
- Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2Prostaglandins, 1977
- Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid.Proceedings of the National Academy of Sciences, 1977
- A radioimmunoassay for thromboxane B2Analytical Biochemistry, 1977
- Prostaglandins H1 and H2. Convenient biochemical synthesis and isolation. Further biological and spectroscopic characterizationProstaglandins, 1977
- Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets.Proceedings of the National Academy of Sciences, 1977
- Radioimmunoassay for Cyclic NucleotidesJournal of Biological Chemistry, 1972